Marcus Stahlberg
Solna, AB 17164, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 70 publications
Safety, pharmacokinetics, and exploratory efficacy of the oral ghrelin receptor agonist AC01 in heart failure with reduced ejection fraction (GOAL-HF1): a randomised, double-blind, placebo-controlled, phase 1b/2a study.
Journal: Lancet (London, England)
Published: April 10, 2026
The Orally Available Ghrelin Receptor-Agonist AC01 Improves Systolic Function in HFrEF Mice and Nonhuman Primates.
Journal: JACC. Basic to translational science
Published: March 31, 2026
Post-COVID Postural Orthostatic Tachycardia Syndrome and Inappropriate Sinus Tachycardia: Prevalence, Overlap, and Clinical Characteristics.
Journal: JACC. Advances
Published: January 26, 2026
Proteomic Remodeling in the Failing Left Ventricle Adapting to Dyssynchrony.
Journal: Proteomics. Clinical applications
Published: January 02, 2026
Long COVID and risk of incident cardiovascular disease: a prospective cohort study using the Multimorbidity Integrated Registry Across Care Levels in Stockholm (MIRACLE-S) cohort.
Journal: EClinicalMedicine
Published: November 07, 2025
Prevalence and Clinical Impact of Postural Orthostatic Tachycardia Syndrome in Highly Symptomatic Long COVID.
Journal: Circulation. Arrhythmia and electrophysiology
Published: September 30, 2025
Screening for postural orthostatic tachycardia syndrome using 24-hour electrocardiogram recording in patients with long coronavirus disease.
Journal: Heart rhythm O2
Published: July 30, 2025
Long-Term Coronary Microvascular and Cardiac Dysfunction After Severe COVID-19 Hospitalization.
Journal: JAMA network open
Published: June 09, 2025
Post-prandial acyl ghrelin infusion in heart failure patients increases gastric emptying rate.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: June 04, 2025
Ten sessions of hyperbaric oxygen versus sham treatment in patients with long covid (HOT-LoCO): a randomised, placebo-controlled, double-blind, phase II trial.
Journal: BMJ open
Published: April 14, 2025
The ghrelin receptor agonist AC01 improves cardiomyocyte contractility through Gαi signalling and without Ca2+ mobilization.
Journal: Cardiovascular research
Published: March 14, 2025
Last Updated: 09/26/2026